461418-01-9

Basic information

• Product Name: (4Z/E,2S)-methyl-1[(2’-methyl-1,1‘-biphenyl-4-yl)-carbonyl]-4-methoxyimino pyrrolidine-2-carboxylate
• Synonyms: (4Z/E,2S)-methyl-1[(2’-methyl-1,1‘-biphenyl-4-yl)-carbonyl]-4-methoxyimino pyrrolidine-2-carboxylate
• CAS NO: 461418-01-9
• Molecular Weight: 366.417
• Mol File: 461418-01-9.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: (4Z/E,2S)-methyl-1[(2’-methyl-1,1‘-biphenyl-4-yl)-carbonyl]-4-methoxyimino pyrrolidine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (4Z/E,2S)-methyl-1[(2’-methyl-1,1‘-biphenyl-4-yl)-carbonyl]-4-methoxyimino pyrrolidine-2-carboxylate(461418-01-9)
• EPA Substance Registry System: (4Z/E,2S)-methyl-1[(2’-methyl-1,1‘-biphenyl-4-yl)-carbonyl]-4-methoxyimino pyrrolidine-2-carboxylate(461418-01-9)

Safety Data

• Hazardous Substances Data: 461418-01-9(Hazardous Substances Data)

Upstream product

• 84348-37-8 N-tert-butoxycarbonyl-4-oxo-L-proline 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 
• 461418-07-5 1-tert-butyl-2-methyl (2S,4EZ)-4-(methoxyimino)pyrrolidine-1,2-dicarboxylate 
• 364077-88-3 (4EZ)-1-(tert-butoxycarbonyl)-4-(methoxyimino)-L-proline 
• 461418-05-3 (4Z/E)-4-methoxyimino-1-[(2’-methyl-1,1’-biphenyl-4-yl)carbonyl]-L-proline 
• 616-42-2 dimethylsulfite 
• 77-78-1 dimethyl sulfate 
• 5748-43-6 4-(2-methylphenyl)benzoic acid 
• 16419-60-6 2-Methylphenylboronic acid 

Downstream Products

• 461418-05-3 (4Z/E)-4-methoxyimino-1-[(2’-methyl-1,1’-biphenyl-4-yl)carbonyl]-L-proline 

Relevant articles and documents

OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE

The disclosure provides compositions and methods for the use of oxytocin antagonists, such as substituted pyrrolidin-3-one oxime derivatives of formula (I), among other compounds, in the treatment of subjects undergoing embryo transfer therapy. The compos

OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE

The invention provides compositions and methods for the use of oxytocin antagonists, such as substituted pyrrolidin-3-one oxime derivatives, among other compounds, in the treatment of subjects undergoing embryo transfer therapy. The compositions and metho

CRYSTALLINE (3Z,5S)-5-(HYDROXYMETHYL)-1-[(2'-METHYL-1,1'-BIPHENYL-4-YL)CARBONYL]PYRROLIDIN-3-ONE O-METHYLOXIME USEFUL IN METHODS OF TREATING CONDITIONS RELATED TO THE OT-R ACTIVITY

Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime is disclosed. A pharmaceutical composition containing the crystalline compound and methods for treating conditions related to the OT-R activity,